| NDR (n = 721) | Non-VTDR (n = 241) | VTDR (n = 53) | p-value | |
---|---|---|---|---|---|
Age (year) | 60.0 (13.0) | 57.0 (14.0) | 56.0 (18.0) | < 0.001 | |
Eye (right, %) | 343 (47.6) | 111 (46.1) | 22 (41.5) | 0.664 | |
Sex (male, %) | 401 (55.6) | 155 (64.3) | 33 (62.3) | 0.049 | |
Duration (months) | 122.0 (97.0) | 131.0 (88) | 157.0 (136) | 0.002 | |
BMI (kg/m2) | 24.60 (4.25) | 24.90 (4.20) | 24.90 (4.45) | 0.306 | |
SBP (mmHg) | 127.0 (21.0) | 126.0 (20.0) | 126.0 (26.0) | 0.766 | |
DBP (mmHg) | 76.0 (12.0) | 78.0 (16.0) | 78.0 (13.0) | 0.441 | |
BUN (mmol/L) | 5.52 (2.01) | 5.52 (2.35) | 6.43 (3.20) | 0.003 | |
SUA (umol/L) | 315.1 (121.0) | 322.5 (120.0) | 356.0 (129.9) | 0.047 | |
 Normal (n, %) | 620 (86.0) | 200 (83.0) | 38 (71.7) | 0.016 | |
 High (n, %) | 101 (14.0) | 41 (17.0) | 15 (28.3) | ||
Scr (µmol/L) | 59.0 (20.7) | 58.8 (23.2) | 65.4 (27.4) | 0.055 | |
eGFR (mL/min/1.73m2) | 100.64 (15.87) | 104.27 (20.89) | 101.99 (24.02) | 0.006 | |
> 120 | 86 (11.9) | 42 (17.4) | 9 (17.0) | 0.016 | |
90–120 | 517 (71.7) | 165 (68.5) | 29 (54.7) | ||
< 89 | 119 (16.5) | 34 (14.1) | 15 (28.3) | ||
TC (mmol/L) | 4.78 (1.63) | 4.89 (1.77) | 4.76 (2.30) | 0.332 | |
TG (mmol/L) | 1.40 (1.00) | 1.58 (1.10) | 1.63 (1.10) | 0.271 | |
HDL-c(mmol/L) | 1.06 (0.39) | 1.01 (0.35) | 1.00 (0.34) | 0.018 | |
LDL-c(mmol/L) | 2.73 (1.33) | 2.83 (1.26) | 2.89 (1.61) | 0.410 | |
ALB (g/L) | 44.80 (5.85) | 44.40 (6.10) | 42.30 (8.65) | < 0.001 | |
HbA1c (%) | 7.80 (2.20) | 8.70 (2.85) | 8.90 (2.90) | < 0.001 | |
< 7 (n, %) | 221 (30.7) | 51 (21.2) | 10 (18.9) | < 0.001 | |
7–9 (n, %) | 314 (43.6) | 89 (36.9) | 17 (32.1) | ||
\(\:\ge\:9\) (n, %) | 186 (25.8) | 101 (41.9) | 26 (49.1) | ||
Glycated albumin | 19.47 (7.65) | 22.50 (8.46) | 24.22 (10.27) | < 0.001 | |
0Â h-PG (mmol/L) | 7.79 (3.13) | 8.43 (3.18) | 7.89 (4.32) | 0.022 | |
1Â h-PG (mmol/L) | 13.26 (5.31) | 12.84 (6.31) | 11.05 (7.93) | 0.056 | |
2Â h-PG (mmol/L) | 13.89 (6.71) | 13.48 (7.39) | 11.73 (9.36) | 0.189 | |
UACR | 14.23 (29.87) | 18.14 (54.52) | 74.86 (365.21) | < 0.001 | |
 Normal (n, %) | 517 (71.7) | 155 (64.3) | 21 (39.6) | < 0.001 | |
 30–300 (n, %) | 163 (22.6) | 60 (24.9) | 16 (30.2) | ||
 > 300 (n, %) | 41 (5.7) | 26 (10.8) | 16 (30.2) | ||
CKD (n, %) | 194 (26.9) | 85 (35.3) | 33 (62.3) | < 0.001 | |
 CKD1 (n, %) | 143 (19.8) | 66 (27.4) | 22 (41.5) | < 0.001 | |
 CKD2 (n, %) | 38 (5.3) | 10 (4.1) | 8 (15.1) | ||
 CKD3 (n, %) | 13 (1.8) | 9 (3.7) | 3 (5.7) | ||
Previous history | Â | Â | Â | Â | |
 Hypertension | 354 (49.1) | 114 (47.3) | 29 (54.7) | 0.786 | |
 Smoking | 271 (37.6) | 116 (48.1) | 21 (39.6) | 0.015 | |
 Drinking | 325 (45.1) | 120 (49.8) | 24 (45.3) | 0.441 | |
 Dyslipidemia | 190 (26.4) | 62 (25.7) | 18 (34.0) | 0.668 | |
 Coronary Heart Disease | 63 (8.7) | 18 (7.5) | 6 (11.3) | 0.790 | |
 Hyperuricemia | 57 (7.9) | 17 (7.1) | 7 (13.2) | 0.323 | |
 Stroke | 35 (4.9) | 11 (4.6) | 4 (7.5) | 0.799 |